Sistemic, RoosterBio Collaborate
News May 29, 2015
The firms will use miRNA-based cell characterization workflows and technologies to develop panels for human MSC products and cell banks, and said that the collaboration "furthers the identification" of miRNA biomarkers across a wide range of donors that may predict hMSC performance. They anticipate offering their customers access to each other's technologies "to enhance the quality, performance, and therapeutic knowledge of MSC technology."
The end goal of the collaboration is to eliminate the functional variability that is inherent in current MSC technology and to accelerate the use of stem cells as a technology, Sistemic and RoosterBio said.
Financial and other terms of the agreement were not disclosed.
"Thorough characterization of hMSC products and cell banks is central to creating a stable, robust technology that can be simply and affordably deployed across a range of applications," RoosterBio Chief Executive Jon Rowley said in a statement. "RoosterBio's rich library of MSC donors married with Sistemic's miRNA characterization platform will provide both predictive biomarkers and critical quality attributes that will allow MSC technology to reach its full potential."
The Ancient Behaviour of Sleep, Conserved Throughout EvolutionNews
The finding that jellyfish sleep implies that sleep is an ancient behavior, largely untouched by millennia of evolution.READ MORE
Gene Immunotherapy Approach Prevents and Reverses Symptoms of Multiple SclerosisNews
Researchers used a viral vector to deliver a gene encoding a myelin sheath protein to the liver, thereby inducing robust and durable immune tolerance in mice by preventing T cells from attacking the myelin sheath.READ MORE
Genetic Code of Neuronal Communication Determines Cell TypeNews
The findings should help scientists sort out the bewildering array of neurons that are intertwined in the brain.READ MORE